Skip to main content
. 2025 Jul 25;15(16):8259–8319. doi: 10.7150/thno.116153

Table 7.

Clinical uses of anti-BC drugs.

Drugs Chemical Structure Ref.
Hydrophobic drugs
Docetaxel graphic file with name thnov15p8259i001.jpg 389
Etoposide graphic file with name thnov15p8259i002.jpg 390
Doxorubicin graphic file with name thnov15p8259i003.jpg 391
Cisplatin graphic file with name thnov15p8259i004.jpg 392
Methotrexate graphic file with name thnov15p8259i005.jpg 393
Paclitaxel graphic file with name thnov15p8259i006.jpg 394
Hydrophilic drugs
Cyclophosphamide graphic file with name thnov15p8259i007.jpg 395
Gemcitabine graphic file with name thnov15p8259i008.jpg 396
5-Fluorouracil graphic file with name thnov15p8259i009.jpg 397
Bevacizumab Monoclonal antibody 398
Pembrolizumab Monoclonal antibody 399
Trastuzumab deruxtecan graphic file with name thnov15p8259i010.jpg 400
Trastuzumab emtansine graphic file with name thnov15p8259i011.jpg 401
Vorinosta graphic file with name thnov15p8259i012.jpg 402